Neurofilament Light Predicts MS Worsening in Silent Progression
NfL changes occurred in advance of, not coincident with, clinical worsening by Judy George, Deputy Managing Editor, MedPage Today October 17,…
Barriers in MS Treatment Adherence
2023 , Octave Although there currently is no cure for multiple sclerosis, in recent decades, 20+ disease-modifying therapies (DMTs)…
Stuart Schlossman
MS Symposium Alabama – Featured Topics: Biosimilars, Bladder Issues, Physical Therapy, MS/relationships and MS Symptoms Management, Treatments and more – plus NMOSD
Watch this (5) Speaker (Presenter) educational program featuring topics on Biosimilars, Bladder Issues, Physical Therapy, MS/relationships and MS Symptoms Management,…
Stuart Schlossman
Smoldering Neuroinflammation – A Resource For HCPs (Healthcare Providers)
HOME Beyond Relapses The Unseen Pathway Smoldering Neuroinflammation …
Stuart Schlossman
More Inflammation Biomarkers in Spinal Fluid of PPMS Patients: Study
Biomarkers show weak correlation with PPMS activity and severity by Patricia Valerio, PhD | November 25, 2022 Individuals with primary progressive multiple sclerosis (PPMS) have…
Stuart Schlossman
MS Living Well Podcast: Multiple Sclerosis Biomarkers including Blood Tests – an interview led by Barry Singer, MD
April 26, 2022 Photo: Rawpixel Rapid recent advancements have led to blood tests (biomarkers) to track multiple sclerosis disease activity.…
Stuart Schlossman
